← Leaderboards
Dewayne Townsend
University Of Michigan At Ann Arbor
$2,617,469
Attributed
$2,617,469
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $490.3K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,617,469 · 3
By mechanism
R01$1,834,666 · 1
K08$641,103 · 1
F32$141,700 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jeffrey S Chamberlain$54,800,495
- Mohammed Akaaboune$6,423,588
- Susan V Brooks$11,089,591
- Mark R Starling$1,170,836
- Emile G Bruneau$55,335
Others in their field
Top investigators on “Dystrophin”
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$43,696,384
- James M Ervasti · University Of Wisconsin Madison$18,166,626
- Elizabeth M McNally · University Of Chicago$15,033,035
- Kevin M Flanigan · Research Inst Nationwide Children'S Hosp$14,737,619
- Krista H Vandenborne · University Of Pennsylvania$13,932,898
- Dongsheng Duan · University Of Florida$13,861,127
Research focus
DystrophinCardiomyopathiesFunctional DisorderComplexMediatingGene TransferSignal TransductionHeart DiseasesSarcoglycansInsightHeartSkeletal Muscle StructurePublic Health RelevanceMuscular Dystrophy, DuchenneCardiacGene TherapyBlood FlowBiologyAuthorityBiochemicalCardiovascular SystemAnimal ModelClinical ResearchContracts
Grant awards (13)
Improving dystrophin gene therapy through understanding dystrobrevin function$373,127
R01 · FY2017 · HL · contact PI
Improving dystrophin gene therapy through understanding dystrobrevin function$373,127
R01 · FY2016 · HL · contact PI
Improving dystrophin gene therapy through understanding dystrobrevin function$367,530
R01 · FY2015 · HL · contact PI
Improving dystrophin gene therapy through understanding dystrobrevin function$365,665
R01 · FY2014 · HL · contact PI
Coronary Regulation in Dystrophic Cardiomyopathy$124,641
K08 · FY2014 · HL · contact PI
Improving dystrophin gene therapy through understanding dystrobrevin function$355,217
R01 · FY2013 · HL · contact PI
Coronary Regulation in Dystrophic Cardiomyopathy$126,971
K08 · FY2013 · HL · contact PI
Coronary Regulation in Dystrophic Cardiomyopathy$129,295
K08 · FY2012 · HL · contact PI
Coronary Regulation in Dystrophic Cardiomyopathy$131,622
K08 · FY2011 · HL · contact PI
Coronary Regulation in Dystrophic Cardiomyopathy$128,574
K08 · FY2010 · HL · contact PI
Dystrophic Cardiomyopathies in mdx$50,428
F32 · FY2006 · HL · contact PI
Dystrophic Cardiomyopathies in mdx$48,296
F32 · FY2005 · HL
Dystrophic Cardiomyopathies in mdx$42,976
F32 · FY2004 · HL